News Detail

Brussels, Belgium and Pune, 12 April 2024: In a landmark collaboration announced today, Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells, a Belgian biotech innovator, targeting a dramatic increase in accessibility ......
View Details
Source : Serum Institute
Serum Institute of India
SII
vaccine manufacturer
Univercells
personalized cancer care
LMIC’s
mRNA
Recombinant BCG
VPM1002
Related News
- 2 antibiotic classes banned for use in animal rearing (13-03-2025)
- DoP organises workshop on PRIP Scheme (13-03-2025)
- Centre and States Prepare to Combat Narcotic Drug Abuse, May Require Barcodes on Packaging (13-03-2025)
- Large consignment of cough syrup recovered before Holi in Madhubani (13-03-2025)
- Poly Medicure gets MDR certification complying EU regulation for 54 products (13-03-2025)
- Assam Rifles, Customs Seize ₹99 Lakh Worth of Banned Phensedyl in Tripura (13-03-2025)
- Treatment of Patients by Unlicensed Practitioners at Medical Store (13-03-2025)
- HC reprimands Punjab for delay in drug probe, sets 10-day limit (13-03-2025)
- Expired Medicine Issue Raised in Assembly (13-03-2025)
- Counterfeiting of medical devices is a severe offense that jeopardizes human lives: Delhi HC (12-03-2025)